When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, researchers reported Thursday in BMJ Open. Adobe stock/HealthDay May 9 ...

Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community-level early warning system for the disease, ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...

Catching pancreatic cancer early is among the most difficult challenges faced by medical providers, and that delay often ends in death. The NIH-supported researchers’ discovery of a new blood test, ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't some cure-all.

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to metastasize, or travel through the blood stream ...

Many people know that finding cancer early, before it spreads, may help increase the chances of treating and surviving cancer ...

Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community level early warning system for the disease, suggests a proof of ...

L1, EBV and mismatch repair deficiency suggests CLDN18.2 stratification must be integrated into multi-biomarker algorithms rather than used in isolation. Treatment interactions emerged: CLDN18.2-high ...